HeartLogic™ in Patients With Heart Failure. | MicrobiomeTrials← Back to trialsNCT07544771
HeartLogic™ in Patients With Heart Failure.
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-04-29Est. Completion: 2028-10-15
Enrollment target: 578 participants Locations- University hospital of Amiens, Amiens, France
- University hospital of Brest, Brest, France
- University hospital of Caen, Caen, France
- University hospital of Grenoble, Grenoble, France
- University hospital of Lille, Lille, France
- La Timone University hospital, Marseille, France
- Hopital du Confluent, Nantes, France
- University hospital of Nantes, Nantes, France
- Georges Pompidou European hospital, Paris, France
- La Pitié Salpétrière, Paris, France
- University hospital of Poitiers, Poitiers, France
- University hospital of Rouen, Rouen, France
- Pasteur clinic, Toulouse, France
- University hospital of Toulouse, Toulouse, France
- University hospital of Tours, Tours, France
Other microbiome trials you might be interested in
Heart Failure
Background:
More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…
Baltimore, United StatesCompleted Apr 30, 2028
Aortic Valve Stenosis
Transcatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed…
Aarhus, DenmarkEst. completion Dec 2027
Ganglioneuroblastoma, NodularNeuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…
Birmingham, United StatesEst. completion Dec 31, 2029